HUP0300985A2 - Megnövelt hatásszélességű gyógyászati készítmény - Google Patents
Megnövelt hatásszélességű gyógyászati készítményInfo
- Publication number
- HUP0300985A2 HUP0300985A2 HU0300985A HUP0300985A HUP0300985A2 HU P0300985 A2 HUP0300985 A2 HU P0300985A2 HU 0300985 A HU0300985 A HU 0300985A HU P0300985 A HUP0300985 A HU P0300985A HU P0300985 A2 HUP0300985 A2 HU P0300985A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- improved spectrum
- hand
- effect
- preparation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000001228 spectrum Methods 0.000 title 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
- 241000208011 Digitalis Species 0.000 abstract 1
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Automotive Seat Belt Assembly (AREA)
Abstract
A találmány tárgya megnövelt hatásszélességű, kardiotonikus hatásúgyógyászati készítmény. A találmány szerinti gyógyászati készítményhatóanyagként egyrészt, egy digitálisz hatású anyagot, másrészt,valamely ciklikus GMP foszfodiészterázgátlót tartalmaz agyógyszerkészítésnél szokásos vivőanyagok mellett. Ó
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0300985A HUP0300985A2 (hu) | 2003-04-15 | 2003-04-15 | Megnövelt hatásszélességű gyógyászati készítmény |
| CA002522143A CA2522143A1 (en) | 2003-04-15 | 2004-04-14 | A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor |
| YUP-2005/0775A RS20050775A (en) | 2003-04-15 | 2004-04-14 | A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor |
| EP04727332A EP1648470A1 (en) | 2003-04-15 | 2004-04-14 | A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor |
| JP2006506247A JP2006523667A (ja) | 2003-04-15 | 2004-04-14 | ジギタリス作用を有する活性成分及びｃＧＭＰホスホジエステラーゼ阻害剤を含有する医薬組成物 |
| PCT/HU2004/000036 WO2004091632A1 (en) | 2003-04-15 | 2004-04-14 | A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor |
| ES05727332T ES2363087T3 (es) | 2003-04-15 | 2005-03-31 | Dispositivo de retracción de correas. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0300985A HUP0300985A2 (hu) | 2003-04-15 | 2003-04-15 | Megnövelt hatásszélességű gyógyászati készítmény |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0300985D0 HUP0300985D0 (en) | 2003-06-28 |
| HUP0300985A2 true HUP0300985A2 (hu) | 2005-07-28 |
Family
ID=90001684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300985A HUP0300985A2 (hu) | 2003-04-15 | 2003-04-15 | Megnövelt hatásszélességű gyógyászati készítmény |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1648470A1 (hu) |
| JP (1) | JP2006523667A (hu) |
| CA (1) | CA2522143A1 (hu) |
| ES (1) | ES2363087T3 (hu) |
| HU (1) | HUP0300985A2 (hu) |
| RS (1) | RS20050775A (hu) |
| WO (1) | WO2004091632A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006128035A2 (en) * | 2005-05-26 | 2006-11-30 | Navitas Pharma, Inc. | Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension |
| NZ724002A (en) * | 2012-05-18 | 2017-07-28 | Luoda Pharma Pty Ltd | Liquid formulation comprising propylene glycol and an ace inhibitor |
-
2003
- 2003-04-15 HU HU0300985A patent/HUP0300985A2/hu unknown
-
2004
- 2004-04-14 WO PCT/HU2004/000036 patent/WO2004091632A1/en not_active Application Discontinuation
- 2004-04-14 CA CA002522143A patent/CA2522143A1/en not_active Abandoned
- 2004-04-14 RS YUP-2005/0775A patent/RS20050775A/sr unknown
- 2004-04-14 JP JP2006506247A patent/JP2006523667A/ja active Pending
- 2004-04-14 EP EP04727332A patent/EP1648470A1/en not_active Withdrawn
-
2005
- 2005-03-31 ES ES05727332T patent/ES2363087T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1648470A1 (en) | 2006-04-26 |
| JP2006523667A (ja) | 2006-10-19 |
| CA2522143A1 (en) | 2004-10-28 |
| ES2363087T3 (es) | 2011-07-20 |
| RS20050775A (en) | 2007-12-31 |
| HUP0300985D0 (en) | 2003-06-28 |
| WO2004091632A1 (en) | 2004-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| SE0001899D0 (sv) | New compounds | |
| EA200700362A1 (ru) | Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью | |
| CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| DK1819227T3 (da) | Farmaceutisk formulering af decitabin | |
| EA200501702A1 (ru) | Устойчивая к манипуляциям дозировочная форма для трансдермального введения | |
| NO20052494L (no) | Preparater inneholdende melatonin, gingko biloba og biotin. | |
| DE60334773D1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| ATE530561T1 (de) | 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| SG166791A1 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| DE60318237D1 (de) | Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol | |
| MY142044A (en) | Endoparasiticidal compositions for topical application | |
| EA200870090A1 (ru) | Применение производных сульфамида, включающих гетероцикл, конденсированный с бензольным кольцом, для лечения депрессии | |
| WO2005075471A3 (en) | Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
| DK1962815T3 (da) | Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer | |
| DK1641803T3 (da) | Thienopyrimidinderivater som kaliumkanalinhibitorer | |
| DE60323765D1 (de) | Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
| WO2005091937A3 (en) | Compositions useful for the treatment of microbial infections | |
| MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
| BRPI0518554A2 (pt) | uso de um inibidor de pde3 | |
| ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol | |
| HUP0300985A2 (hu) | Megnövelt hatásszélességű gyógyászati készítmény |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |